Tuberculosis vaccine (adenovirus type 5 vector)(Cansino Biotechnology)
肺结核疫苗（5型腺病毒载体）（康希诺生物）
Report date: 2025/11/14 17:23:05
Base Information
Drug NameTuberculosis vaccine (adenovirus type 5 vector)(Cansino Biotechnology)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesTianjin Cansino Biotechnology Inc
China Registration ClassN/A
Develop Information
Active CompaniesTianjin Cansino Biotechnology Inc
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A